Aurora Cannabis Partners with Leafio to Expand Medical Cannabis Access Across Australia

Expanding Horizons: Aurora Cannabis and Leafio Join Forces in Australia

In a significant move aimed at improving medical cannabis accessibility, Aurora Cannabis Inc. has announced a partnership with Leafio Australia. The collaboration is expected to enhance access to safe and effective medical cannabis for patients throughout Australia, ensuring that healthcare professionals have the necessary resources to support their patients effectively.

About the Partnership

This strategic alliance involves Aurora's wholly owned subsidiary, MedReleaf Australia, which has teamed up with Leafio—Montu Australia's wholesale distribution arm. By combining their strengths, they aim to provide consistent access to high-quality medical cannabis through educational programs for healthcare providers. Leafio will distribute Aurora’s extensive range of cannabis products, including top brands like MedReleaf, CraftPlant, Whistler Cannabis Co., and IndiMed.

Stanley Sack, Interim Managing Director of MedReleaf Australia, expressed enthusiasm about the partnership, stating, “We are excited to join forces with Leafio to improve access to consistent, high-quality medical cannabis for Australian patients. Our TGA-GMP certified products combined with Leafio's extensive sector knowledge make us ideal partners.”

Nicole Le Maistre, General Manager of Leafio, echoed this sentiment, emphasizing that the partnership will facilitate broader access to world-class products. She noted, “Together, Leafio and Aurora can reach more Australian patients through trusted medical channels, bolstering access to world-class products and expertise.”

Significant Benefits for Patients and Providers

The collaboration is expected to bring various benefits to the medical cannabis landscape in Australia. Aurora's products will be available through Leafio's nationwide distribution network, which serves over 4,000 pharmacies. This move is anticipated to simplify the process for patients seeking high-quality medical cannabis, bridging the gap between patients and trusted healthcare practitioners.

In addition to improving product access, the partnership aims to foster increased research and product innovation within the region's medical cannabis industry. By focusing on clinician education, both companies hope to raise awareness and knowledge about effective medical cannabis solutions, ultimately leading to improved patient outcomes.

Aurora Cannabis and Its Mission

Aurora Cannabis is a pioneer in the global cannabis industry, dedicated to providing high-quality products to both medical and consumer markets in Canada, Europe, Australia, and New Zealand. Headquartered in Edmonton, Alberta, the company is committed to advancing the field of cannabis and helping individuals improve their quality of life. The company's diverse brand portfolio caters to both medical and recreational users, confirming its dedication to quality and innovation in cannabis.

As Aurora continues to forge partnerships and expand its footprint globally, the collaboration with Leafio stands out as a vital step toward improving patient access to medical cannabis in Australia.

For more information about Aurora Cannabis products or to connect with healthcare professionals, visit MedReleaf Australia's website.

The future of medical cannabis in Australia looks promising, and with this strategic partnership, Aurora and Leafio are positioning themselves at the forefront of a thriving industry.